Skip to main content
Log in

Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip)

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Objectives

We assessed the prevalence of moderately severe or severe mitral regurgitation (MR) justifying edge-to-edge mitral valve (MV) repair (MitraClip®) in patients attending the University Hospital Wuerzburg, a tertiary care centre located in Wuerzburg, Germany.

Background

Transcatheter edge-to-edge MV repair of advanced MR is a non-surgical treatment option in inoperable and high-risk patients. It is unknown how many patients are potentially eligible for MitraClip® since several anatomical prerequisites of the MV apparatus have to be met for optimal treatment results.

Methods

Using a novel clinical data warehouse we searched for all patients attached to our Department of Internal Medicine from 01/2008 to 01/2012 with moderately severe or severe MR and aged ≥18 years. The current status of their treatment regime and eligibility for MitraClip® was assessed and re-evaluated according to current guidelines and echocardiographic criteria.

Results

The search of electronic medical records amongst 43,690 patients employed an innovative validated text extraction method and identified 331 patients with moderately severe or severe MR who had undergone echocardiographic assessment at our institution. Of these, 125 (38 %) received MV surgery and 206 (62 %) medical therapy only. Most patients not undergoing surgery had secondary MR (70 %). After evaluation of medical and echocardiographic data of medically treated patients (n = 206), 81 (39 %) were potential candidates for MitraClip® therapy, and 90 (44 %) died during the median follow-up time of 23 months.

Conclusion

A large fraction of patients with moderately severe or severe MR but not operated was detected. Medically treated patients had a bad prognosis and about 40 % of them were potential candidates for MitraClip® therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA et al (2014) 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. doi:10.1161/CIR.0000000000000031

    Google Scholar 

  2. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M et al (2001) The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 122(4):674–681. doi:10.1067/mtc.2001.117277

    Article  CAS  PubMed  Google Scholar 

  3. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R et al (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54(8):686–694. doi:10.1016/j.jacc.2009.03.077

    Article  PubMed  Google Scholar 

  4. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P et al (2005) Percutaneous mitral valve repair using the edge-to-edge technique: 6-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 46(11):2134–2140. doi:10.1016/j.jacc.2005.07.065

    Article  PubMed  Google Scholar 

  5. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R et al (2012) Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 59(2):130–139. doi:10.1016/j.jacc.2011.08.067

    Article  PubMed  Google Scholar 

  6. Georg Fette ME, Anja Wörner, Peter Klügl, Stefan Störk, Frank Puppe. (2012) Information extraction from unstructured electronic health records and integration into a data warehouse. GI-Jahrestagung, volume 208 von LNI, Seite 1237–1251 GI

  7. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C et al (2010) European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 11(4):307–332. doi:10.1093/ejechocard/jeq031

    Article  PubMed  Google Scholar 

  8. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ et al (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17(10):1086–1119. doi:10.1016/j.echo.2004.07.013

    PubMed  Google Scholar 

  9. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H et al (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezs455

    Google Scholar 

  10. Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C et al (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96. doi:10.1007/s00392-013-0614-x

    Article  CAS  PubMed  Google Scholar 

  11. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011. doi:10.1016/S0140-6736(06)69208-8

    Article  PubMed  Google Scholar 

  12. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24(13):1231–1243. doi:10.1016/S0002-9149(98)01064-9

    Article  PubMed  Google Scholar 

  13. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL et al (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83(6):897–902

    Article  CAS  PubMed  Google Scholar 

  14. Cohn LH, Couper GS, Aranki SF, Rizzo RJ, Kinchla NM, Collins JJ Jr (1994) Long-term results of mitral valve reconstruction for regurgitation of the myxomatous mitral valve. J Thorac Cardiovasc Surg 107(1):143–150

    CAS  PubMed  Google Scholar 

  15. Cooper GJ, Wright EM, Smith GH (1991) Mitral valve repair: a valuable procedure with good long term results even when performed infrequently. Br Heart J 66(2):156–160

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, Frye RL (1995) Congestive heart failure after surgical correction of mitral regurgitation. A long-term study. Circulation 92(9):2496–2503. doi:10.1161/01.CIR.92.9.2496

    CAS  PubMed  Google Scholar 

  17. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL et al (2007) What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 28(11):1358–1365. doi:10.1093/eurheartj/ehm001

    Article  PubMed  Google Scholar 

  18. Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J et al (2001) Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 122(6):1125–1141. doi:10.1067/mtc.2001.116557

    Article  CAS  PubMed  Google Scholar 

  19. Grossi EA, Goldberg JD, LaPietra A, Ye X, Zakow P, Sussman M et al (2001) Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg 122(6):1107–1124. doi:10.1067/mtc.2001.116945

    Article  CAS  PubMed  Google Scholar 

  20. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45(3):381–387. doi:10.1016/j.jacc.2004.09.073

    Article  PubMed  Google Scholar 

  21. Goel SS, Bajaj N, Aggarwal B, Gupta S, Poddar KL, Ige M et al (2014) Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol 63(2):185–186. doi:10.1016/j.jacc.2013.08.723

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Comprehensive Heart Failure Center Würzburg, Würzburg, Germany (BMBF grant 01EO1004).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank Weidemann.

Ethics declarations

Conflict of interest

F. W. acknowledges a research grant support from Abbott Laboratories, Abbott Park, IL, USA. All other authors declare no conflicts of interest, including any financial relationship with industry relevant to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wallenborn, J., Störk, S., Herrmann, S. et al. Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip). Clin Res Cardiol 105, 699–709 (2016). https://doi.org/10.1007/s00392-016-0975-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-016-0975-z

Keywords

Navigation